Surrozen, Inc. Warrant (SRZNW)

• Market cap: $71.6K
• 1 day: 102.73%
• 5 days: 102.73%
• 1 month: 24.58%
• 3 months: -11.51%
• 6 months: -27.12%
• Year to date: -31.38%
• 1 year: 48.67%
• 5 years: -98.79%
• 10 years: -98.79%
• Sector: Healthcare
• Industry: Biotechnology

About: Surrozen Inc is a clinical-stage biotechnology company committed to discovering and developing drug candidates to selectively modulate the Wnt pathway, a critical mediator of tissue repair, in a broad range of organs and tissues. Its product candidate includes SZN-1326 (Fzd5/Lrp6, SWAP), SZN-413 and SZN-043 (E3/ASGR1, SWEETS).

Employees: 41

Fund manager confidence

Based on 2025 Q2 regulatory disclosures by fund managers ($100M+ AUM)

100% more first-time investments, than exits

New positions opened: 2 | Existing positions closed: 1

6% more funds holding

Funds holding: 18 [Q1] → 19 (+1) [Q2]

0.51% more ownership

Funds ownership: 94.51% [Q1] → 95.01% (+0.51%) [Q2]

0% more funds holding in top 10

Funds holding in top 10: 2 [Q1] → 2 (+0) [Q2]

25% less capital invested

Capital invested by funds: $867K [Q1] → $650K (-$217K) [Q2]

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 2